Assessment of systemic corticosteroid activity

Area of Science:

• Endocrinology
• Pulmonology
• Pharmacology

Background:

• Inhaled corticosteroids (ICS) are widely used for managing respiratory conditions.
• Concerns exist regarding the potential impact of ICS on the hypothalamic-pituitary-adrenal (HPA) axis.
• Understanding the risk of adrenal insufficiency with ICS use is crucial for patient safety.

Purpose of the Study:

• To evaluate the risk of adrenal crisis in patients using inhaled corticosteroids.
• To determine the relationship between ICS dosage, duration, and HPA axis effects.
• To assess the likelihood of acute adrenal insufficiency in patients on ICS therapy.

Main Methods:

• Review of existing literature on inhaled corticosteroid effects on the HPA axis.
• Analysis of factors influencing HPA axis suppression, including ICS potency and dose.
• Assessment of adrenal crisis risk based on the degree of HPA axis suppression.

Main Results:

• ICS potency, dose, and treatment duration influence HPA axis effects.
• Minimal to modest HPA axis suppression is observed at low/medium ICS doses.
• The risk of adrenal crisis is considered extremely unlikely with standard ICS use.

Conclusions:

• In patients using inhaled corticosteroids, the risk of acute adrenal insufficiency and subsequent adrenal crisis is very low.
• Low/medium doses of ICS are associated with minimal HPA axis suppression, mitigating the risk of adrenal crisis.
• Clinical management should consider these findings to reassure patients and guide therapy.